首页|基于U937-NF-κB-Luc细胞系的阿达木单抗生物学活性快速检测方法的建立及验证

基于U937-NF-κB-Luc细胞系的阿达木单抗生物学活性快速检测方法的建立及验证

扫码查看
目的 建立基于U937-NF-κB-Luc细胞系的阿达木单抗生物学活性快速检测方法,并进行验证.方法 以U937-NF-κB-Luc细胞系为效应细胞,通过荧光素酶发光原理建立阿达木单抗生物学活性检测方法,并优化方法的肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)浓度(以160 ng/mL为初始浓度,进行2倍系列稀释,共10个稀释度)、抗体起始浓度(起始终浓度设为2 000 ng/mL,进行2倍系列稀释,共20个稀释度)、抗体稀释倍数(1.5、2、3、4倍)、细胞接种量(8×103、2×104、4×104、6×104个/孔)、孵育时间(0.5、1、2、3 h),验证方法的专属性、准确性、精密性及线性范围.采用优化的方法及基于L929细胞的TNF-α中和活性法分别检测5批阿达木单抗的相对效价.结果 阿达木单抗国际标准品的剂量-效应曲线呈典型的S型,且所得数据符合四参数方程式:y=(A-D)/[1+(x/C)B]+D,R2>0.99.确定最适TNF-α浓度为5 ng/mL,抗体起始浓度为800 ng/mL,抗体稀释倍数为2倍,细胞接种量为2 × 104个/孔,诱导时间为2 h.阿达木单抗等3种TNF-α靶点的治疗性单抗均可获得较好的剂量-效应曲线,其他非TNF-α靶点的治疗性单抗未呈现该曲线;效价理论值对数与其实测值对数的直线回归方程的斜率为1.037,相对偏倚均在±12%范围内;各效价样品的相对效价测定值的几何变异系数(geometric coefficient of variation,GCV)均<20%;理论效价在64%~156%范围内,与检测值呈良好的线性关系,拟合直线回归方程为y=1.037 4 x-0.023 7,R2=0.998 4.两种方法检测5批阿达木单抗的相对效价检测结果差异无统计学意义(t=1.198,P=0.265 1).结论 建立的基于U937-NF-κB-Luc细胞系的阿达木单抗生物学活性检测方法具有良好的专属性、准确性及精密性,且耗时短(仅需3h),可作为阿达木单抗生物学活性的快速评价方法.
Development and verification of a rapid detection method for adalimumab biological activity based on U937-NF-κB-Luc cell line
Objective To develop and verify a rapid detection method for the biological activity of adalimumab based on U937-NF-κB-Luc cell line.Methods Using U937-NF-κB-Luc cell line as the detection cells,a method for detecting the biological activity of adalimumab was developed based on luciferase luminescence principle.The method was optimized for the concentration of tumor necrosis factor-α(TNF-α)(160 ng/mL as initial concentration,2 times serial dilution,10 dilutions),the initial concentration of antibody(2 000 ng/mL,2 times serial dilution,20 dilutions),the dilution multiple of antibody(1.5,2,3,4 times),the inoculation amount(8 × 103,2 × 104,4 × 104,6 × 104 cells/well)and the incubation time(0.5,1,2,3h),and verified for the specificity,accuracy,precision and linear range.The relative potency of five batches of adalimumab was detected by using the optimized method and TNF-α neutralization activity method based on L929 cells respectively.Results The dose-response curve of adalimumab international standard showed a typical S-type,and the data complied with the four-parameter equation y=(A-D)/[1+(x/C)B]+D,R2>0.99.The optimum concentration of TNF-α was 5 ng/mL,the initial concentration of antibody was 800 ng/mL,the dilution ratio for adalimumab was 1∶2,the inoculation amount was 2 × 104 cells/well,and the induction time was 2 h.Three therapeutic monoclonal antibodies of TNF-α target,such as adalimumab,obtained good dose-response curves,while therapeutic monoclonal antibodies of other non-TNF-α targets did not show this curve.The linear regression equation of the logarithmic value of theoretical potency and the logarithmic value of the corresponding measured potency had a slope of 1.037,and the relative bias was within the range of±12%.The geometric coefficient of variation(GCV)of the relative titer measured value of each sample was less than 20%.The theoretical potency ranged from 64%to 156%,showing a good linear relationship with the measured values,and the fitting linear regression equation was y=1.037 4 x-0.023 7,R2=0.998 4.There was no significant difference in the relative potency measured results of five batches of adalimumab by the two methods(t=1.198,P=0.265 1).Conclusion The developed detection method for adalimumab biological activity based on U937-NF-κB-Luc cell line has good specificity,accuracy and precision with short time consumption(3 h),which can be used as a rapid evaluation method for the biological activity of adalimumab.

AdalimumabU937-NF-κB-Luc cellsTumor necrosis factor-α(TNF-α)Biological activity

郭莎、贾哲、龙彩凤、黄璟、贺鹏飞、高洁、于传飞、徐刚领、刘万卉、王兰

展开 >

中国食品药品检定研究院 国家卫生健康委员会生物技术产品检定方法及标准化重点实验室 国家药品监督管理局生物制品质量研究与评价重点实验室,北京 102629

烟台大学药学院,山东烟台 264005

阿达木单抗 U937-NF-κB-Luc细胞 肿瘤坏死因子-α 生物学活性

国家重点研发计划2020年国家药品标准提高课题

2021YFF06008042020S08

2024

中国生物制品学杂志
中华预防医学会,长春生物制品研究所有限责任公司

中国生物制品学杂志

CSTPCD
影响因子:0.417
ISSN:1004-5503
年,卷(期):2024.37(1)
  • 3